MktsMarkets

GeneDx Holdings Corp.
NASDAQ: WGSKey statistics
WGS News
Stories mentioning WGS from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 102,254 | 120,989 | 116,743 | 102,692 | 87,115 | 95,640 | 76,874 | 70,514 |
| Cost of Goods Sold | 34,043 | 36,721 | 32,216 | 31,790 | 28,639 | 29,435 | 29,045 | 27,562 |
| Gross Profit | 68,211 | 84,268 | 84,527 | 70,902 | 58,476 | 66,205 | 47,829 | 42,952 |
| Operating Expenses | ||||||||
| Research & Development | 19,804 | 24,541 | 19,829 | 15,079 | 12,577 | 11,588 | 11,665 | 10,902 |
| Sales General & Admin | 74,591 | 50,450 | ||||||
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | (57,471) | (14,235) | (3,251) | 8,960 | (4,551) | 8,806 | (7,780) | (10,579) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | (206.00) | (4,591) | (174.00) | 239.00 | 209.00 | (714.00) | 1,144 | (13,481) |
| Pretax Income | (62,419) | (18,230) | (7,388) | 10,563 | (6,082) | 5,414 | (8,359) | (29,363) |
| Tax Provision | 897.00 | (564.00) | 247.00 | (246.00) | 447.00 | (24.00) | (47.00) | (190.00) |
| Net Income (Loss) | (63,316) | (17,666) | (7,635) | 10,809 | (6,529) | 5,438 | (8,312) | (29,173) |
| Earnings Per Share (Basic) | (2.16) | (0.62) | (0.27) | 0.38 | (0.23) | 0.20 | (0.31) | (1.10) |
| Earnings Per Share (Diluted) | (2.16) | (0.62) | (0.27) | 0.36 | (0.23) | 0.20 | (0.31) | (1.10) |
| Weighted Average Shares Outstanding (Basic) | 29,335 | 28,642 | 28,798 | 28,580 | 28,148 | 26,891 | 27,096 | 26,618 |
| Weighted Average Shares Outstanding (Diluted) | 29,335 | 28,642 | 28,798 | 29,754 | 28,148 | 26,891 | 27,096 | 26,618 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About WGS
GeneDx Holdings Corp. (NASDAQ: WGS) is a stock listed on the Nasdaq Stock Market under the ticker symbol WGS. It last traded at $49.48 (Nov 13, 2026, 10:58 AM ET), down 4.6% on the day. That gives GeneDx a market capitalisation of $1.6B.
Over the past 52 weeks WGS has traded between $32.21 and $170.87.
Revenue for the quarter ended Mar 31, 2026 was $102.3M; a net loss of $63.3M. Revenue was up 17.4% from $87.1M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $102.3M | -$63.3M | -61.9% |
| Dec 31, 2025 | $121.0M | -$17.7M | -14.6% |
| Sep 30, 2025 | $116.7M | -$7.6M | -6.5% |
| Jun 30, 2025 | $102.7M | $10.8M | 10.5% |
From GeneDx’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…